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httpsWHAT THIS PAPER ADDS
This is the ﬁrst study to investigate the role of calcium scoring in aneurysmal aortic disease. A well validated
assessment of arterial calcium scoring is described and demonstrates excellent reproducibility of score as-
sessments within the arterial segments described. These data show high scores are associated with poor out-
comes and lend weight to the possibility of calcium scoring in clinical practice as a predictive tool of poor
cardiovascular outcomes in patients with aneurysmal disease.Introduction: Cardiovascular events are common in people with aortic aneurysms. Arterial calciﬁcation is a
recognised predictor of cardiovascular outcomes in coronary artery disease. Whether calciﬁcation within
abdominal and thoracic aneurysm walls is correlated with poor cardiovascular outcomes is not known.
Patients and methods: Calcium scores were derived from computed tomography (CT) scans of consecutive
patients with either infrarenal (AAA) or descending thoracic aneurysms (TAA) using the modiﬁed Agatston score.
The primary outcome was subsequent all cause mortality during follow-up. Secondary outcomes were
cardiovascular mortality and morbidity.
Results: A total of 319 patients (123 TAA and 196 AAA; median age 77 [71e84] years, 72% male) were included
with a median follow-up of 30 months. The primary outcome occurred in 120 (37.6%) patients. In the abdominal
aortic aneurysm group, the calcium score was signiﬁcantly related to both all cause mortality and cardiac
mortality (odds ratios (OR) of 2.246 (95% CI 1.591e9.476; p < 0.001) and 1.321 (1.076e2.762; p ¼ 0.003))
respectively. In the thoracic aneurysm group, calcium score was signiﬁcantly related to all cause mortality (OR
6.444; 95% CI 2.574e6.137; p < 0.001), cardiac mortality (OR 3.456; 95% CI 1.765e4.654; p ¼ 0.042) and cardiac
morbidity (OR 2.128; 95% CI 1.973e4.342; p ¼ 0.002).
Conclusions: Aortic aneurysm calciﬁcation, in either the thoracic or the abdominal territory, is signiﬁcantly
associated with both higher overall and cardiovascular mortality. Calcium scoring, rapidly derived from routine CT
scans, may help identify high risk patients for treatment to reduce risk.
 2018 The Authors. Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an open
access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Arterial calciﬁcation is now recognised as a signiﬁcant
marker of poor cardiovascular outcome. This is most evident
within the coronary circulation. Coronary artery calciﬁcation
can be quantiﬁed using the Agatston score; an independent
predictor of future coronary events.1 Furthermore, the
process atherosclerosis is a systemic inﬂammatory condi-
tion not only exclusive to the coronary or aortic circulation.authors contributed equally to the study.
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://doi.org/10.1016/j.ejvs.2017.11.007Arterial calciﬁcation is a systemic pathological process
and as such can affect other arterial beds. Traditionally,
calciﬁcation of both the abdominal and thoracic aorta has
not been studied in the same detail as the coronary arterial
circulation. Non-aneurysmal abdominal aortic calciﬁcation is
strongly associated with both mortality and cardiovascular
events rates with similar associations seen when consid-
ering the calciﬁc burden of the thoracic aorta.2,3
Both the abdominal and descending thoracic aorta are
prone to aneurysmal degeneration. Abdominal aortic an-
eurysms are the most common form of aortic aneurysm,
affecting 5% of the males aged 65e74.4 Thoracic aortic
aneurysms have a more heterogeneous aetiology including
atherosclerosis alongside less common genetic inﬂuences.
The emergence of endovascular intervention has revo-
lutionised the management of aneurysmal disease,
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Such conditions however are still associated with signiﬁcant
long-term risk, speciﬁcally the risk of major cardiovascular
events.6 As such, there is a continuing need for robust
methods to predict such longer-term outcomes.
The evidence base for the predictive value of arterial
calciﬁcation in aortic disease is limited, with only a small
number of studies and no assessment in aneurysmal dis-
ease.2,7 As such, and given the increasing use of CT based
imaging modalities in the assessment of aneurysmal aortic
disease, more in depth analysis of potential associations is
both timely and warranted.
The primary aim of this study was to determine whether
aortic aneurysmal calciﬁcation (the AAC score) could predict
(a) all causemortality and (b) cardiovascular related outcomes
in a large, consecutive, well characterised cohort of patients
with either thoracic and abdominal aortic aneurysms.
METHODS
Patient identiﬁcation
This was a retrospective, observational, single centre study
consisting of consecutive asymptomatic patients undergoing
CT angiography of either a thoracic aortic aneurysm (January
2008 to January 2012) or abdominal aortic aneurysm (January
2010 to January 2013), presenting to Addenbrooke’s Hospital,
Cambridge, UK. This study was registered with the local audit
department to ensure all data collection was in line with local
ethical standards. Radiology digital records were searched
and all patients with a CT angiogram of the aorta identiﬁed.
All CT scans were screened and an aneurysm diagnosis made
when the largest single segment of the appropriate part of the
aorta (infrarenal abdominal or thoracic) had an antero-
posterior diameter of 3 cm or greater. Electronic patient re-
cords were reviewed to collect follow-up data, up to the ﬁnal
date of May 2015. Mortality and morbidity data were ob-
tained from hospital medical records (cross-referenced with
ONS data), hospital death certiﬁcates, and where further
clariﬁcation was required general practitioners were con-
tacted to access community medical notes, and community
death certiﬁcates to ascertain the cause of death. Patients
with a proven ruptured aneurysm or those imaged because of
symptomatic aneurysms as well as patients with ascending or
arch aneurysms were excluded (given the management of
these patients in separate specialist cardiothoracic centre).
Patients with aneurysms due to other causes (i.e., vasculitis)
were also excluded. Patients with synchronous thoracic and
abdominal aortic aneurysms were excluded to allow
comparative analysis of calciﬁcation in these patients and to
avoid confounding factors.
Patient demographics, medical history, and medication at
the time of CT imaging were determined from the hospital
electronic record system. Ischaemic heart disease (IHD) was
deﬁned as a clinical diagnosis of angina, a prescription of
anti-anginal drugs, or a history of myocardial infarction or a
coronary revascularisation procedure.
The primary endpoint was all cause mortality within the
follow-up period with secondary endpoints of cardiacmortality and cardiac morbidity. Cardiac mortality was
deﬁned as death with documented evidence of acute
myocardial infarction (MI). Cardiac morbidity was deﬁned as
a hospital admission with either (1) typical cardiac chest
pain with ischaemic electrocardiogram (ECG) changes, or (2)
typical chest pain with elevated cardiac enzymes, or (3) a
discharge coding of a coronary event. Events were classiﬁed
by the attending medical teams (in hospital event) or pa-
thologists at post mortem (community event). Where hos-
pital data were missing, data were sourced either from the
primary care team or from the death certiﬁcate.
Measurement of arterial calciﬁcation using the AAC score
Patients underwent CT imaging on a 64 slice CT scanner
(Somatom Deﬁnition AS, Siemens, Crawley, UK), using
standard clinical protocols. Brieﬂy, scans were performed
using helical acquisition with kV ¼ 120, mA ¼ 200, and a
ﬁeld of view of 350e380 mm yielding typical spatial reso-
lution 0.7  0.7  3.0 mm3. Images were read and reported
by consultant interventional vascular radiologists and
maximum diameter was calculated using both AP diameters
as well as double oblique reformats to the centreline.
Diagnosis was based on enhanced CT imaging. ECG gating
was not used in the thorax scans. From acquired raw data,
the scan was reconstructed in 3 mm slices. Image analysis
was performed on an Apple Macintosh computer (Apple
Inc, Cupertino, CA, USA) using the open source DICOM
viewer (v4, OsiriX Imaging Software, Pixmeo SARL).
Calciﬁcation data were derived from unenhanced CT
images. Patients without unenhanced CT images were
excluded. Using the freely available “Calcium Scoring” plug-
in, vascular calciﬁcation (based on an attenuation threshold
of 130 Hounsﬁeld Units in 3 contiguous voxels, after the
method of Agatston8) was analysed on consecutive trans-
axial slices along the length of the arterial segment, as
previously described9 (Fig. 1).
For the purposes of the thoracic aorta, the strict
anatomical boundaries were from just distal to the left
subclavian artery (proximal) to the proximal aspect of the
coeliac axis (distal). For the abdominal aorta boundaries,
analysis from the lowermost renal artery (proximal) down
to the common iliac artery bifurcation on both limbs (distal)
was performed. The AAC score was a cumulative score of
each segment for both the thoracic aorta and the infrarenal
abdominal aorta (including both aneurysmal and non-
aneurysmal segments). No assessment of coronary cal-
cium was made (inadequate and un-gated scans).
AAC scoring reproducibility
Inter-observer reproducibility of the AAC scores was
determined in 10 patients by two experienced readers
(M.M.C. and L.P.Z./J.J.S., for both thoracic (J.J.S.) and
abdominal (L.P.Z.) scans, respectively). Intra-observer
reproducibility was determined for the AAC scores by an
expert reader blinded to patient demographics (M.M.C.) for
both thoracic and abdominal aneurysms. Fifteen unen-
hanced CT scans were scored on two occasions 7 days apart.
Table 1. Baseline patient demographics (AAA).
(n ¼ 196)
Age, years 77 (69e83)
Male 160 (82)
Medical history at time of scan
Ischaemic heart disease 46 (23)
Hypertension 59 (30)
Diabetes mellitus 18 (9)
Hypercholesterolaemia 43 (22)
Current smoker 58 (30)
Medications
Antiplatelet agent 65 (33)
Statin use 32 (16)
Values are median (quartile 1 to quartile 3) or n (%).
Figure 1. Calculation of calcium score using OsiriX. Example of
thoracic aortic aneurysm scoring with scores derived from distal to
left subclavian to upper aspect of coeliac axis using OsiriX.
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Statistical analyses were performed using SPSS (version 23,
IBM, Armonk, NY, USA). The normality of continuous vari-
ables was checked using the KolmogoroveSmirnov test; this
demonstrated that AAC scores were non-parametric, which
were logarithmically transformed for further analysis.10
Variables are expressed as mean  standard deviation,
median (Quartile 1 to Quartile 3) or n (%), as appropriate.
Multivariate logistic regression adjusted analysis was per-
formed to determine the individual parameters correlated
with AAC. Receiver-operator characteristic (ROC) curves
were generated for both scores against the primary
outcome. Cutoff values were generated for equally
weighted sensitivities and speciﬁcities. Intra- and inter-
observer reproducibility was tested using intraclass corre-
lation coefﬁcients (ICC). A p value < 0.05 was considered
statistically signiﬁcant.
RESULTS
Abdominal aortic aneurysm
A total of 196 patients with AAA were included in the study.
Demographic data are shown in Table 1. The median age
was 78 (72e84) years; 160 (81.6%) were male. Fifty-eight
(30.0%) were current smokers, 46 (23.4%) had a diagnosis
of IHD, and 21 (10.7%) prior cerebrovascular disease. The
average maximum aneurysm diameter was 55 (47e66.3)
mm. 103 (53%) patients underwent repair of their AAA
during follow-up (85 endovascular, 18 open repair). The
median AAAC score was 14,216 (7986e23,261). There was
no signiﬁcant difference between the operated and non-
operated group (score, 14,911 vs. 13,978; p > 0.05,
respectively).
There were 38 (19.4%) deaths during the follow up
period of 22 (3e48) months. These included 10 patients
who died because of myocardial infarction, two patientsfrom left ventricular failure following an MI, and two
gastrointestinal haemorrhages leading to fatal MI. Further-
more, there were 11 deaths attributed to pneumonia, seven
end stage malignancy, two ruptured AAAs, and four with
cause unknown. Only two deaths (MI and pneumonia)
occurred within 30 days of operative intervention. Assess-
ment of parameters, after correction for confounders
(including age and sex) was by a multivariate regression
analysis. The AAAC score was signiﬁcantly related to the
primary outcome with an OR 2.246 (95% CI 1.591e9.476;
p < 0.001) (Table 2).
Cardiac mortality occurred in 14 patients (7.1%) and
cardiac morbidity in 20 patients (10.2%; comprising of 17
patients diagnosed with a MI, 2 patients with decom-
pensated heart failure and 1 patient admitted with unstable
angina). AAAC score was predictive of cardiac mortality (OR
1.321 [1.076e2.762]; p ¼ 0.003) (Table 3), but despite a
clear correlation of pre-existing cardiac disease and cardiac
morbidity (p ¼ 0.001), there was no correlation between
calcium score and cardiac morbidity (OR 1.231; 95% CI
0.872e1.453; p ¼ 0.341).
No documented complications were encountered due to
common femoral/access points or further infrainguinal
arterial calciﬁcation.
ROC analysis curves were generated to test the power of
the AAAC score to predict all cause mortality and the sec-
ondary outcomes (Fig. 2a and b). For all cause mortality, an
AUC value of 0.815 (95% CI 0.755e0.875; p < 0.001)
demonstrated that a cutoff value of >21,000 (at a sensi-
tivity of 84%, speciﬁcity of 74.6%) would predict the
outcome. For cardiac mortality, an AUC value of 0.748 (95%
CI 0.633e0.864; p ¼ 0.02) demonstrated that a cutoff value
of >22,500 (at a sensitivity of 78.6%, speciﬁcity of 68.3%)
would predict the outcome.
Inter- and intra-observer reliability scores for AAC were
ICC 0.93 and 0.95, respectively.
Thoracic aortic aneurysm
A total of 123 patients with thoracic aneurysms were
included in the study. The median age of this cohort was 77
(70e83) years; 74 (60%) were male. Demographic data are
shown in Table 4. Forty-one (33%) were current smokers, 64
Table 3. Secondary outcome: Cardiac mortality (AAAC group).
Univariate logistic regression Multivariate logistic regression
OR 95% CI p OR 95% CI p
Age 1.065 1.021 1.137 0.048 1.232 0.987 1.982 0.078
Male Sex 0.725 0.155 3.393 0.683 e e
Diabetes 0.753 0.198 2.857 0.676 e e
HTN 1.643 0.524 5.152 0.395 e e
Smoker 0.624 0.207 1.880 0.402 e e
IHD/MI 0.689 0.229 2.074 0.507 e e
Antiplatelet 1.231 0.325 4.661 0.759 e e
Statin 2.283 0.752 6.934 0.145 e e
Diameter 1.237 0.897 1.707 0.195 e e
Ca2þ score 1.192 1.075 2.472 0.002 1.321 1.076 2.762 0.003
Note. Signiﬁcance is highlighted in bold. HTN ¼ hypertension; IHD/MI ¼ ischaemic heart disease/myocardial infarction; OR ¼ odds ratio;
CI ¼ conﬁdence interval.
Table 2. Primary outcome: All cause mortality (AAAC group).
Univariate logistic regression Multivariate logistic regression
OR 95% CI p OR 95% CI p
Age 1.112 1.067 1.158 <0.001 1.084 1.032 1.138 0.001
Male sex 1.857 0.895 3.852 0.096
Diabetes 0.976 0.456 2.089 0.949
HTN 1.689 0.884 3.228 0.113
Smoker 0.835 0.453 1.540 0.564
IHD/MI 0.881 0.482 1.612 0.681
Antiplatelet 2.134 1.027 4.433 0.042 0.625 0.202 1.934 0.415
Statin 2.346 1.224 4.496 0.010 1.427 0.526 3.873 0.486
Diameter 0.978 0.810 1.181 0.817
Ca2þ score 3.706 2.641 9.591 <0.001 2.246 1.591 9.476 <0.001
Note. Signiﬁcance is highlighted in bold. HTN ¼ hypertension; IHD/MI ¼ ischaemic heart disease/myocardial infarction; OR ¼ odds ratio;
CI ¼ conﬁdence interval.
104 Mohammed M. Chowdhury et al.(52%) had pre-existing IHD and 23 (19%) prior cerebrovas-
cular disease. The average maximum aneurysm diameter
was 62 (53e67.5) mm, with 75 (61%) patients undergoing
endovascular repair during the follow up period. No pa-
tients underwent open repair. The median TAAC score for all
patients was 6263 (1168e16,165). There was no signiﬁcantFigure 2. (a) ROC analysis e all cause mortality (abdominal aortic ane
p < 0.001). (b) ROC analysis e cardiac mortality (abdominal aortic
p ¼ 0.02). AAC ¼ aneurysmal aortic calcium; ROC ¼ receiver-operatodifference between the operated and non-operated group
(score 5296 vs. 6210; p > 0.05, respectively).
During follow-up of 45 (10e55) months, there were 46
(37%) deaths. The leading causes were myocardial infarction
(n ¼ 10), acute left ventricular failure (n ¼ 2), gastroin-
testinal haemorrhage leading to a myocardial infarctionurysms). AUC for the AAC score was 0.815 (95% CI 0.755e0.875;
aneurysms). AUC for the score was 0.748 (95% CI 0.633e0.864;
r curve; AUC ¼ area under the curve; CI ¼ conﬁdence interval.
Table 4. Baseline patient demographics (thoracic aortic
aneurysms).
(n ¼ 123)
Age, years 78 (72e84)
Male 74 (60)
Medical history at time of scan
Ischaemic Heart Disease 42 (34)
Hypertension 41 (33)
Diabetes Mellitus 21 (17)
Hypercholesterolaemia 51 (41)
Current smoker 41 (33)
Medications
Antiplatelet agent 53 (43)
Statin use 48 (39)
Values are median (quartile 1 to quartile 3) or n (%).
Calciﬁcation of Thoracic and Abdominal Aneurysms 105(n ¼ 1), ruptured aneurysm (n ¼ 9), pneumonias (n ¼ 7),
malignancy (n ¼ 6), intracerebral bleed (n ¼ 1), and
vascular dementia in one patient. In nine patients, the
cause of death was not determined. Only two deaths (MI)
occurred within 30 days of operative intervention. Again,
following multivariate regression analysis, the TAAC score
was signiﬁcantly related to the primary outcome (OR 6.444;
95% CI 2.574e6.137; p < 0.001) (Table 5).
Cardiac mortality occurred in 13 patients (11%) and car-
diac morbidity in 17 patients (14%; comprising 15 patients
with a diagnosis of MI and 2 patients with a diagnosis of
unstable angina). TAAC score was predictive of cardiac
mortality (OR 3.456 [1.765e4.654]; p ¼ 0.042) (Table 6),
and cardiac morbidity (OR 2.128; 95% CI 1.973e4.342;
p ¼ 0.002) (Table 7).
No documented complications were encountered due to
common femoral/access points or further infrainguinal
arterial calciﬁcation.
ROC analysis curves were generated to test the power of
the AAC score to predict all cause mortality and both sec-
ondary outcomes (Fig. 3aec). For all cause mortality, an
area under the curve (AUC) value of 0.785 (95% CI 0.704e
0.865; p < 0.001) demonstrated that a cutoff value of
>5800 (at a sensitivity of 82.6%, speciﬁcity of 73.4%) would
predict the outcome. For the secondary outcomes, cardiac
mortality (AUC 0.712; 95% CI 0.595e0.828; p ¼ 0.013) a
cutoff value of >5500 (at a sensitivity of 84.6%, speciﬁcityTable 5. Primary outcome: All cause mortality (TAAC group).
Univariate logistic regression
OR 95% CI p
Age 1.054 1.014 1.095 0.007
Male Sex 0.907 0.431 1.910 0.797
Diabetes 1.613 0.578 4.503 0.362
HTN 1.046 0.485 2.257 0.908
Smoker 0.901 0.417 1.950 0.792
IHD/MI 0.704 0.328 1.512 0.368
Antiplatelet 0.738 0.354 1.535 0.416
Statin 1.265 0.608 2.631 0.530
Diameter 0.748 0.551 1.017 0.064
Ca2þ Score 6.054 2.845 6.898 <0.0
Note. Signiﬁcance is highlighted in bold. HTN ¼ hypertension; IHD/MI
CI ¼ conﬁdence interval.of 75.6%) would predict the outcome, whereas with cardiac
morbidity (AUC 0.840; 95% CI 0.768e0.912; p < 0.001)) a
cutoff value of >6100 (at a sensitivity of 82.4%, speciﬁcity
of 79.8%) would predict the outcome.
DISCUSSION
In this study, calciﬁcation of both the aneurysmal thoracic
and the infrarenal abdominal aorta was predictive of all
cause mortality. Furthermore, these relationships remained
signiﬁcant after correcting for potential confounders (such
as age and blood pressure) in a multivariate regression
analysis. In addition, AAC was correlated with adverse car-
diac speciﬁc mortality irrespective of site of aneurysmal
disease. Quantitative assessment of AAC score, using
computed tomography, was feasible, highly reproducible,
and has been proven to be a useful surrogate for long-term
clinical outcomes. Interestingly, after regression analysis
assessing the predictive power of aneurysm size and cal-
cium score, it was only score that proved signiﬁcant to
predict the outcomes, irrespective of aneurysm size. Spe-
ciﬁcally, this study also provides appropriate cutoff values
for calcium scoring that predict patient relevant outcomes
for both the thoracic and abdominal aorta. These now
require further prospective validation.
The endovascular revolution has transformed how
aneurysm disease is now managed. Increasingly, endog-
rafting is the ﬁrst line treatment.11 Within the abdominal
aorta this move towards endovascular aortic repair (EVAR)
is associated with an early survival advantage that is sub-
sequently eroded at 5 years.12 However, such short-term
beneﬁts have encouraged the treatment of older patients
with greater comorbidity.13 Pre-operative assessment and
risk stratiﬁcation is key in these patients; the ability to be
build a robust operative risk tool, perhaps with the inclusion
of calcium score, could help identify patients at higher risk
of post-operative complications.
Aneurysm calcium scoring could have a role in risk
stratiﬁcation of patients (in particular when assessing pa-
tient ﬁtness and disease burden pre-operatively). The pro-
cess of scoring is a quick and reproducible technique that
could easily be employed in clinical practice (similar to
coronary scoring). OsiriX is freely available software andMultivariate logistic regression
OR 95% CI p
1.016 0.974 1.061 0.460
01 6.444 2.574 6.137 <0.001
¼ ischaemic heart disease/myocardial infarction; OR ¼ odds ratio;
Table 6. Secondary outcome: Cardiac mortality (TAAC group).
Univariate logistic regression Multivariate logistic regression
OR 95% CI p OR 95% CI p
Age 1.021 0.968 1.077 0.444
Male sex 1.558 0.452 5.370 0.483
Diabetes 2.667 0.328 21.706 0.359
HTN 1.546 1.142 2.103 0.034 1.765 0.987 2.543 0.087
Smoker 0.383 0.120 1.227 0.106
IHD/MI 0.811 0.248 2.653 0.729
Antiplatelet 0.581 0.179 1.888 0.367
Statin 0.478 0.139 1.645 0.242
Diameter 0.844 0.530 1.346 0.477
Ca2þ score 4.790 1.102 20.817 0.037 3.456 1.765 4.654 0.042
Note. Signiﬁcance is highlighted in bold. HTN ¼ hypertension; IHD/MI ¼ ischaemic heart disease/myocardial infarction; OR ¼ odds ratio;
CI ¼ conﬁdence interval.
Table 7. Secondary outcome: Cardiac morbidity (TAAC group).
Univariate logistic regression Multivariate logistic regression
OR 95% CI p OR 95% CI p
Age 1.047 0.991 1.106 0.105 e e e e
Male Sex 0.407 0.144 1.157 0.092 e e e e
Diabetes 0.955 0.248 3.668 0.946 e e e e
HTN 0.551 0.168 1.808 0.325 e e e e
Smoker 0.904 0.309 2.645 0.853 e e e e
IHD/MI 1.531 1.189 2.497 0.023 1.672 1.098 1.897 0.345
Antiplatelet 0.649 0.230 1.833 0.415 e e e e
Statin 0.433 0.143 1.314 0.139 e e e e
Diameter 1.245 0.822 1.886 0.300 e e e e
Ca2þ score 9.609 4.079 22.639 0.005 2.128 1.973 4.342 0.002
Note. Signiﬁcance is highlighted in bold. HTN ¼ hypertension; IHD/MI ¼ ischaemic heart disease/myocardial infarction; OR ¼ odds ratio;
CI ¼ conﬁdence interval.
106 Mohammed M. Chowdhury et al.there is an easy to use plug-in which allows the scoring of
calcium from CT images. As reported, intra- and inter-
observer variability was minimal. The approximate time to
score the aneurysm was 3 min per scan.
The data are less strong when assessing thoracic aortic
aneurysms. No randomised controlled trials have compared
thoracic EVAR (TEVAR) with conventional open surgicalFigure 3. (a) ROC analysis e all cause mortality (thoracic aortic aneu
p < 0.001). (b) ROC analysis e cardiac mortality (thoracic aortic ane
p ¼ 0.013. (c) ROC analysis e cardiac morbidity (thoracic aortic ane
p < 0.001). AAC ¼ aneurysmal aortic calcium; ROC ¼ receiver-operatrepair, yet a recent Cochrane review concluded that TEVAR
was associated with a reduction in early outcomes including
paraplegia, mortality, and hospital stay. A lack of available
high quality data limited the conclusions with regard to
longer-term outcomes.14 It is recognised that patients with
aneurysm disease have signiﬁcant cardiovascular risk and
that there is an association with increasing diameter.15rysm). AUC for the AAC score was 0.785 (95% CI 0.704e0.865;
urysm). AUC for the AAC score was 0.712 (95% CI 0.595e0.828;
urysm). AUC for the AAC score was 0.840 (95% CI 0.768e0.912;
or curve; AUC ¼ area under the curve; CI ¼ conﬁdence interval.
Calciﬁcation of Thoracic and Abdominal Aneurysms 107Here, it is shown that calcium score is also an independent
risk factor of overall cardiovascular risk.
Given the increasing use such interventions, speciﬁcally
within the older patients, as well as the overall associated
cardiovascular event risk, there is a continuing need to
identify those patients with an overall reduced life expec-
tancy. This will allow focused cardiovascular risk factor
management in such patients as well as enhancing the
decision making process when an aneurysm reaches the size
threshold for intervention. This study shows that the burden
of aortic calciﬁcation is an accurate predictor of poor pa-
tient outcome. It is a clinically relevant measure, as all pa-
tients being considered for intervention will undergo CT
evaluation. The determination of calciﬁcation is straight-
forward to perform and excellent reliability has been
shown.
Calciﬁcation occurs in response to chronic inﬂammation,
a key process in the development of aortic aneurysm dis-
ease. Calciﬁcation seen in the aorta is found within the
intimal and medial layers of the arterial wall. In contrast,
there is predominantly intimal calciﬁcation seen within the
atherosclerotic plaques in the coronary arteries. Medial
calciﬁcation is strongly associated with aging, diabetes and
end stage disease.16 Yet evidence suggests that calciﬁcation
occurs differently within differing arterial beds, with the
associations between calciﬁed atherosclerosis and mortality
also different depending on vascular bed.17 It is thought
that the calcium deposition in the vessel wall leads to
vascular stiffness and subsequent hypertension.18 The as-
sociation between coronary artery calciﬁcation and mor-
tality is clear.19 In the non-aneurysmal aorta, thoracic aortic
calciﬁcation is associated with total mortality and all car-
diovascular events whereas abdominal aortic calciﬁcation is
associated more with cardiovascular mortality and
morbidity. When other arterial beds are considered, there
has been shown to be marked variability in degree of
calciﬁcation and patient outcomes suggesting that the
location and severity of calciﬁcation provides unique infor-
mation for mortality.10
In this study, mortality due to cardiovascular causes
occurred in up to 10% of the study cohort. Pneumonia was
also a cause of death in a substantial number of cases and
may well reﬂect patients with poor respiratory reserve in
keeping with a signiﬁcant smoking history, a further risk for
arterial calciﬁcation. Interestingly, there was no signiﬁcant
correlation between calcium score and cardiac morbidity.
This may, in part, be due to low outcome numbers and
generally small sample sizes. This lends further weight to
the role of calcium scoring as a predictor of poor outcomes
given that such patients may not have been identiﬁed as
previously needing aggressive secondary cardiovascular risk
prevention. Why do patients with increased arterial calciﬁ-
cation have higher rates of morbidity and mortality? In part,
this may reﬂect a generalised lower grade chronic inﬂam-
matory process which has been associated with a number
of diseases associated with ageing.20,21 It may also be that
patients with AAAs have associated atherosclerotic risk
factors and therefore have an increased prevalence ofcoronary heart disease and risk of cardiovascular
events.22,23 This probably reﬂects the demographics of AAA
patients who tend to be older men with a history of
smoking. Arterial calciﬁcation itself, speciﬁcally within the
aorta, is likely to contribute to arterial stiffening and sub-
sequent hypertension.24 This undoubtedly is a potential
aetiological factor in the development of cardiovascular
morbidity and mortality.Limitations
This study was a retrospective study, although a complete
dataset was obtained. A pragmatic study design was used
and as such included all patients with an asymptomatic
aneurysm irrespective of whether they underwent surgical
intervention or not, so some patients did succumb to a
ruptured aneurysm within the follow up, although these
numbers were small. Aneurysms of the ascending thoracic
aorta and arch as well as symptomatic aneurysms were not
included in the analysis. This was a CT speciﬁc study to allow
for calcium scoring and so the study cohort reﬂects (a)
those patients with an AAA reaching threshold for treat-
ment and (b) patients undergoing treatment/surveillance
with a thoracic aneurysm. It therefore doesn’t reﬂect pa-
tients undergoing ultrasound surveillance for a small AAA or
those patients being assessed using magnetic resonance
angiography (MRA), although MRA is little used within the
practice. As such, those patients with the most severe co-
morbidity in whom a decision not to treat was made
without CT imaging may well not be represented within this
cohort of patients. Speciﬁcally renal dysfunction was not
analysed, a recognised cause of calciﬁcation, given that the
lack of CT angiography in such patients due to the perceived
risk of contrast nephropathy may well have biased the re-
sults. As such, this study is reﬂective of clinical practice. It
would also be useful to investigate the link between
aneurysmal calcium score and coronary artery calcium
score. Furthermore, the assessment of calcium burden was
not correlated with the presence of peripheral arterial dis-
ease (using ankle brachial pressure index; ABPI). There may
be merit in assessing this correlation with further studies,
given its association with cardiovascular morbidity and
mortality. ABPI data were not available for this cohort of
patients.
In current practice, use of non-contrast CT of the chest is
rapidly emerging as a screening tool for identifying
asymptomatic patients at high risk of heart disease, as well
as having a role in lung cancer screening.25
CONCLUSION
Given the routine use of CT angiography in the assessment
of patients with aneurysmal disease, the role of calcium
scoring in aneurysmal disease has potential to help identify
patients at higher risk of longer-term morbidity and mor-
tality, and this warrants prospective validation. The data
identify a cohort of patients with increased risk of poor
outcomes. Further understanding of the calciﬁcation pro-
cess may help to improve cardiovascular outcomes.
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